Charles River Laboratories International has agreed to spend US$510 million to acquire the assets of its Cambodia-based provider of non-human primates for biomedical, pharmaceutical, and toxicological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback